Back
Corcept Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
CORT
Corcept Therapeutics
Last Price:
$72.98
Seasonality Move:
6.42%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.74 | Sell |
| 20-day SMA: | 67.38 | Buy |
| 50-day SMA: | 65.35 | Buy |
| 200-day SMA: | 49.53 | Buy |
| 8-day EMA: | 73.17 | Sell |
| 20-day EMA: | 57.15 | Buy |
| 50-day EMA: | 32.55 | Buy |
| 200-day EMA: | 9.93 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 18.38 | Buy |
| Relative Strength Index (14 RSI): | 53.08 | Buy |
| Chaikin Money Flow: | 1380584 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.45 - 79.41) | Buy |
| Bollinger Bands (100): | (50.9 - 69.84) | Buy |
Corcept Therapeutics Technical Analysis
| Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 72.97 while CORT 8-day simple moving average is 82.74, which is a Sell signal.
-
The stock price of CORT is 72.97 while Corcept Therapeutics 20-day SMA is 67.38, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 65.35 while CORT share price is 72.97, making it a Buy technically.
-
CORT stock price is 72.97 and Corcept Therapeutics 200-day simple moving average is 49.53, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
53
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $72.97. The Score for CORT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
7.7B
Price in USD:
72.97
Share Volume:
2.3M
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
20.84
Buy
53
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 72.97 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 72.97 while CORT 8-day exponential moving average is 73.17, which is a Sell signal.
-
The stock price of CORT is 72.97 while Corcept Therapeutics 20-day EMA is 57.15, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 32.55 while CORT share price is 72.97, making it a Buy technically.
-
CORT stock price is 72.97 and Corcept Therapeutics 200-day simple moving average is 9.93, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 18.38, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 53.08, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (50.45 - 79.41), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (50.9 - 69.84), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.